Umbipro H-W-3799

Name of the medicinal product


Opinion holderGlaxoSmithKline Trading Services
Active substance

Chlorhexidine digluconate

International non-proprietary name or common nameChlorhexidine
Pharmaco-therapeutic group

Antiseptics and disinfectants, biguanides and amidines

ATC codeD08AC02
Therapeutic indication

Umbipro is indicated for prophylaxis of omphalitis (infection of the umbilical cord) in newborn infants.

Orphan medicinal product designation dateNot applicable

*This document includes:

Annex I - Summary of product characteristics
Annex IIA - Manufacturer responsible for batch release
Annex IIB - Recommendations to the opinion holder - conditions of use
Annex IIIA - Labelling
Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.

How useful was this page?

Add your rating